EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Systemic Effects of Inhaled Corticosteroids: An Overview

Dhruti Pandya, Amar Puttanna, Viswanatha Balagopal

The Open Respiratory Medicine Journal · 31.12.2014 · 8 (1) · 59-65

DOI: 10.2174/1874306401408010059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Respiratory Medicine Journal, erschienen am 31.12.2014. Verfasst von Dhruti Pandya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Walsall Manor Hospital, West Midlands, WS2 9PS, UK. Die Arbeit wurde bisher 107-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhaled corticosteroids (ICS) are common medications, used in respiratory medicine for controlling conditions such as asthma and other obstructive airway diseases. The systemic effects of oral corticosteroids are well known and established; inhaled steroids have been known to cause relatively minor and localized adverse effects such as oral candidiasis. However, less attention has been paid to their systemic effects. Although currently there is a paucity of prospective studies demonstrating the systemic effects of inhaled corticosteroids, there are numerous retrospective studies adding evidence to this link. Inhaled corticosteroids can affect the hypothalamo-pituitary-adrenal axis, bone density and growth, eyes, skin and immunity including an increased risk of pneumonia. Clinicians are recommended to aim for the lowest possible dose to avoid these systemic side effects. Fluticasone is more likely to cause systemic effects compared to budesonide. Newer ICS molecules such as ciclesonide may be more beneficial in reducing such systemic complications on prolonged use. This paper provides an updated overview of the common systemic effects encountered with ICS treatment.

Schlagwörter

Stichwörter der Autor:innen

Asthmachronic obstructive pulmonary disease (COPD)diabetes progressionhypothalamo-pituitary-adrenal axisinhaled corticosteroids (ICS)systemic adverse effects.

Autor:innen und Institutionen

  • Department of Endocrinology, Walsall Manor Hospital, West Midlands, WS2 9PS, UK.
  • Department of Respiratory Medicine, Walsall Manor Hospital, Walsall, West Midlands, WS2 9PS, UK.

Zitieren

APA

Pandya, D., Puttanna, A., & Balagopal, V. (2014). Systemic Effects of Inhaled Corticosteroids: An Overview. The Open Respiratory Medicine Journal, 8(1), 59-65. https://doi.org/10.2174/1874306401408010059

Vancouver

Pandya D, Puttanna A, Balagopal V. Systemic Effects of Inhaled Corticosteroids: An Overview. The Open Respiratory Medicine Journal. 2014;8(1):59-65. doi:10.2174/1874306401408010059

BibTeX
@article{Pandya2014,
  author = {Pandya, Dhruti and Puttanna, Amar and Balagopal, Viswanatha},
  title = {Systemic Effects of Inhaled Corticosteroids: An Overview},
  journal = {The Open Respiratory Medicine Journal},
  year = {2014},
  volume = {8},
  number = {1},
  pages = {59--65},
  doi = {10.2174/1874306401408010059}
}
Kostenlos starten →